Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome

被引：89

作者：

Shang, Fu-Jun ^{[1
]}

Wang, Jie-Pin ^{[2
]}

Liu, Xiong-Tao ^{[1
]}

Zheng, Qiang-Sun ^{[1
]}

Xue, Yu-Sheng ^{[1
]}

Wang, Bin ^{[1
]}

Zhao, Lian-You ^{[1
]}

机构：

[1] Fourth Mil Med Univ, Dept Cardiol, Tangdu Hosp, Xian 710038, Shaanxi, Peoples R China

[2] Fourth Mil Med Univ, Dept Pharm, Tangdu Hosp, Xian 710038, Shaanxi, Peoples R China

来源：

BIOMARKERS | 2011年 / 16卷 / 08期

关键词：

Adipokines; biomarker; cardiometabolic syndrome; coronary atherosclerosis index; CHOLESTEROL; INFLAMMATION; ADIPOKINES; MORTALITY;

D O I：

10.3109/1354750X.2011.622789

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Context: Omentin-1, an adipokine secreted from visceral adipose tissue, has been reported to be associated with coronary artery disease (CAD) and metabolic disorders. Objective: To clarify the relationship between serum omentin-1 levels and the presence and severity of CAD in patients with metabolic syndrome (MetS). Methods: We measured serum omentin-1 levels in 175 consecutive patients with MetS and in 46 controls. Results: Serum omentin-1 levels are inversely associated with the presence and angiographic severity of CAD in MetS patients. Conclusions: Serum omentin-1 might be a potential biomarker to predict the development and progression of CAD in MetS patients.

引用

页码：657 / 662

页数：6

共 50 条

[1] Association of serum omentin-1 levels with coronary artery disease
Xia Zhong
Hai-yang Zhang
Hui Tan
Yi Zhou
Fu-li Liu
Fu-qin Chen
De-ya Shang
Acta Pharmacologica Sinica, 2011, 32 : 873 - 878
[2] Association of serum omentin-1 levels with coronary artery disease
Zhong, Xia
Zhang, Hai-yang
Tan, Hui
Zhou, Yi
Liu, Fu-li
Chen, Fu-qin
Shang, De-ya
ACTA PHARMACOLOGICA SINICA, 2011, 32 (07) : 873 - 878
[3] Serum levels of osteocalcin are inversely associated with the metabolic syndrome and the severity of coronary artery disease in Chinese men
Bao, Yuqian
Zhou, Mi
Lu, Zhigang
Li, Huating
Wang, Ye
Sun, Leiqing
Gao, Meifang
Wei, Meng
Jia, Weiping
CLINICAL ENDOCRINOLOGY, 2011, 75 (02) : 196 - 201
[4] Serum sLOX-1 levels are associated with the presence and severity of angiographic coronary artery disease in patients with metabolic syndrome
Li, Bo
Zhang, Li-hua
Yang, Xin-guo
Liu, Xiong-tao
Ren, Yin-gang
CLINICAL AND INVESTIGATIVE MEDICINE, 2010, 33 (06): : E398 - E404
[5] Effect of atorvastatin on serum omentin-1 in patients with coronary artery disease
Chen, Qianqian
Shang, Xingchen
Yuan, Meng
Liang, Lining
Zhong, Xia
CORONARY ARTERY DISEASE, 2017, 28 (01) : 44 - 51
[6] Correlation of metabolic syndrome with serum omentin-1 and visfatin levels and disease severity in psoriasis and psoriatic arthritis
Dagdelen, Deniz
Karadag, Ayse Serap
Kasapoglu, Esen
Wang, Jordan V.
Erman, Hayriye
DERMATOLOGIC THERAPY, 2020, 33 (06)
[7] Omentin-1 levels in patients with premature coronary artery disease, metabolic syndrome and healthy controls. Short communication
Stejskal, David
Vaclavik, Jan
Smekal, Ales
Svobodova, Gabriela
Richterova, Radmila
Svestak, Marek
BIOMEDICAL PAPERS-OLOMOUC, 2016, 160 (02): : 219 - 221
[8] Serum levels of visfatin and omentin-1 in patients with psoriasis and their relation to disease severity
Ismail, S. A.
Mohamed, S. A.
BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 (02) : 436 - 439
[9] Elevated Serum Chemerin Levels are Associated with the Presence of Coronary Artery Disease in Patients with Metabolic Syndrome
Dong, Baokang
Ji, Weihua
Zhang, Yanjun
INTERNAL MEDICINE, 2011, 50 (10) : 1093 - 1097
[10] Correlation between sLOX-1 and Omentin-1 Levels and the Severity of Coronary Artery Disease in the Elderly
Chen, Xi
Zhang, Na
Liang, Xiaohui
Hu, Guangmei
Xu, Xinjuan
INTERNATIONAL JOURNAL OF GERONTOLOGY, 2023, 17 (01) : 39 - 43

← 1 2 3 4 5 →